- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Percentage of critical U.S. drug shortages by admission route and type 2011-2013
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Percentage of critical U.S. drug shortages by admission route and type 2011-2013
Percentage of critical drug shortages in the United States between June 2011 and June 2013, by route of admission and product type
This statistic depicts critical drug shortages in the United States from June 2011 through June 2013, distributed by route of administration and product type. In that period, some 18 percent of all critical drug shortages concerned orally-administered drugs only available in generic form.
Percentage of critical drug shortages in the United States between June 2011 and June 2013, by route of admission and product type
| Percentage of drug shortages | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Percentage of drug shortages | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- February 2014
- Region
- United States
- Survey time period
- June 2011 to June 2013
Source
- Show sources information
- Show publisher information
- Release date
- February 2014
More information
- Region
- United States
- Survey time period
- June 2011 to June 2013
Other statistics on the topic
+Pharmaceutical Products & Market
Pfizer's top products based on revenue 2018
+Pharmaceutical Products & Market
Merck & Co.'s top-selling drugs 2016-2018
+Pharmaceutical Products & Market
Top therapeutic classes by global pharmaceutical sales 2018 estimates
Pharmaceutical Products & Market
Top pharmaceutical products by sales worldwide 2018
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate solution including all features.
Prices do not include sales tax.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
- Global overview
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Pfizer's top 10 products based on revenue in 2018 (in million U.S. dollars)Pfizer's top products based on revenue 2018
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)Novartis' top drugs based on revenue 2018
- Top selling products of Merck & Co. based on revenue from 2016 to 2018 (in million U.S. dollars)Merck & Co.'s top-selling drugs 2016-2018
- Selected top drugs of pharmaceutical company Roche from 2015 to 2018, based on revenue (in million Swiss francs)Pharmaceutical company Roche: top drugs based on revenue 2015-2018
- Sanofi's selected top pharmaceutical products based on revenue in 2017 and 2018 (in million euros)Sanofi top pharmaceutical products 2017-2018
- Select therapy classes - global
- Top 5 global vaccine products based on revenue in 2017 and 2024 (in million U.S. dollars)Leading five global vaccine products by revenue 2017 and 2024
- Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*Top 5 worldwide oncology products by revenue 2017 and 2024
- Top anti-diabetic products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*Top worldwide anti-diabetic products prediction by revenue 2017 and 2024
- Top 5 global anti-viral products based on revenue in 2017 and 2024 (in million U.S. dollars)Leading five global anti-viral products by revenue 2017 and 2024
- Top anti-rheumatic products based on global revenue in 2017 and 2024 (in million U.S. dollars)Top worldwide anti-rheumatics by revenue 2017 and 2024
- U.S. overview
- Top 20 U.S. therapy areas based on drug spending in 2018 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2018
- Top 20 U.S. pharma products by dispensed prescriptions in 2018 (in millions)Top U.S. pharma products by prescriptions 2018
- Top 20 branded drugs in the U.S. based on total number of prescriptions in 2014-2015U.S. top 20 branded drugs based on prescriptions 2014-2015
- Top 20 prescription drugs based on U.S. sales in 2018 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2018
- Select therapy classes - U.S.
- Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)Top U.S. oncology products by revenue in 2016
- Top 20 respiratory brands in the U.S. based on revenue in 2016 (in million U.S. dollars)Revenue of top 20 respiratory brands in the U.S. 2016
- Top 20 neurology products in the U.S. based on revenue in 2016 (in million U.S. dollars)*Revenue of top 20 neurology products in the U.S. 2016
- Selected top psychiatric drugs' U.S. revenue in 2016 (in million U.S. dollars)Top psychiatric drugs in the United States by sales 2016
- Top 20 health products for women in the U.S. based on revenue in 2016 (in million U.S. dollars)Revenue from top 20 women health products in the U.S. 2016
- Leading autoimmune disease products in the United States in 2016, by sales (in billion U.S. dollars) Leading autoimmune disease products U.S. 2016, by sales
- Number of critical drug shortages in the U.S. by therapeutic class 2011-2013
- Percentage of critical U.S. drug shortages by therapeutic class 2011-2013
- Causes of drug shortages in the U.S. 2011-2013
- Active drug shortages 2007-2013
- Duration of drug shortages in the U.S. 2007-2013
- Top drug classes prescribed to seniors in Canada 2016, by rate of use
- Multiple sclerosis management products in development in the U.S. 2014
- Pharmaceutical drug production value Japan 2016, by prefecture
- Top approved MS therapies in the U.S. by ARR 2014
- Top drug classes prescribed to seniors living in LTC in Canada 2016, by rate of use
- Hormone replacement therapy - women with drug prescription by ethnicity 2001-2008
- Orphan drugs
- Top pharmaceutical drugs
- Generic Drugs in Canada, 2018
- Orphan Drugs in the United States (Part one)
- Assessing Canada’s Drug Shortage Problem
- Drug use in Denmark
- Drug use in the Nordic countries
- Over-the-counter medicine industry in the United Kingdom
- Orphan Drugs in the United States (Part two)
- Generics and biosimilars
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2017 Year-En...
- Generic Drugs in Canada, 2016
- Narcotic Drugs Report 2018
- 2019 Generic Drug & Biosimilars Access & Savings in the United States Report
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Top pharmaceutical products by sales worldwide 2018
- Pfizer's top products based on revenue 2018
- Novartis' top drugs based on revenue 2018
- Merck & Co.'s top-selling drugs 2016-2018
- Pharmaceutical company Roche: top drugs based on revenue 2015-2018
- Sanofi top pharmaceutical products 2017-2018
- Leading five global vaccine products by revenue 2017 and 2024
- Top 5 worldwide oncology products by revenue 2017 and 2024
- Top worldwide anti-diabetic products prediction by revenue 2017 and 2024
- Leading five global anti-viral products by revenue 2017 and 2024
- Top worldwide anti-rheumatics by revenue 2017 and 2024
- Leading therapy areas for U.S. drug spending 2018
- Top U.S. pharma products by prescriptions 2018
- U.S. top 20 branded drugs based on prescriptions 2014-2015
- U.S. top 20 prescribed drugs based on sales 2018
- Top U.S. oncology products by revenue in 2016
- Revenue of top 20 respiratory brands in the U.S. 2016
- Revenue of top 20 neurology products in the U.S. 2016
- Top psychiatric drugs in the United States by sales 2016
- Revenue from top 20 women health products in the U.S. 2016
- Leading autoimmune disease products U.S. 2016, by sales
- Number of critical drug shortages in the U.S. by therapeutic class 2011-2013
- Percentage of critical U.S. drug shortages by therapeutic class 2011-2013
- Causes of drug shortages in the U.S. 2011-2013
- Active drug shortages 2007-2013
- Duration of drug shortages in the U.S. 2007-2013
- Top drug classes prescribed to seniors in Canada 2016, by rate of use
- Multiple sclerosis management products in development in the U.S. 2014
- Pharmaceutical drug production value Japan 2016, by prefecture
- Top approved MS therapies in the U.S. by ARR 2014
- Top drug classes prescribed to seniors living in LTC in Canada 2016, by rate of use
- Hormone replacement therapy - women with drug prescription by ethnicity 2001-2008
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.